Fig.Ā 8From: Mutations in fibroblast growth factor (FGF8) and FGF10 identified in patients with conotruncal defectsScheme of the regulatory mechanisms involving FGF8 and FGF10 in the pathogenesis of CTDs. The upward arrow indicates increased expression, the downward arrow indicates decreased secretion, and the minus sign indicates inhibitionBack to article page